SCHEMBL5929123

SCHEMBL5929123

CCc1cccc(CC)c1-c1nc(-c2ccccc2)c(CN2CCCCC2c2ccc3c(c2)OCO3)n1CC

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ TERT O14746 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GPR35 Q9HC97 1/20 0.40
▸ ACHE P22303 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ SIGMAR1 Q99720 2/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ C5AR1 P21730 1/20 0.36
▸ CPT2 P23786 1/20 0.36
▸ CPT1A P50416 1/20 0.36
▸ FAAH O00519 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929306 0.92 C5AR1 (0.44) POLBALDH1A1KMT2ALMNATERT
SCHEMBL5929070 0.91 KMT2A (0.41) POLBALDH1A1KMT2ALMNATERT
SCHEMBL5929363 0.88 KMT2A (0.39) ALDH1A1KMT2ALMNAMEN1RAB9A
SCHEMBL5929062 0.88 POLB (0.46) POLBALDH1A1KMT2ALMNAMEN1
SCHEMBL5929061 0.88 POLB (0.39) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL5929135 0.85 GAA (0.41) ALDH1A1KMT2ARAB9ASMN1; SMN2KDM4E
SCHEMBL5929192 0.84 KMT2A (0.39) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL5929042 0.84 CFB (0.38) ALDH1A1KMT2ALMNARAB9AKDM4E
SCHEMBL5929141 0.84 KMT2A (0.38) ALDH1A1KMT2ALMNARAB9AKDM4E
SCHEMBL5929028 0.84 C5AR1 (0.52) POLBALDH1A1KMT2ALMNATERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 POLB 4751/4885ALDH1A1 3884/4885KMT2A 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback